If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
81.00    2.20 (2.79%)
Bid:
79.20
Ask:
80.80
Spread: 1.60 (2.02%)
Market Cap: £562.36m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Transaction in Own Shares

23 Aug 2024 07:00

RNS Number : 4977B
GlobalData PLC
23 August 2024
 

23 August 2024

 

 

GlobalData Plc

 

Transaction in Own Shares

 

 

GlobalData Plc ('GlobalData' or the 'Group') announces that, in accordance with the terms of its share buyback programme announced and commenced on 31 July 2024 (the "Share Buyback Programme"), the Company purchased the following number of its ordinary shares of £0.0001 each through Panmure Liberum Limited.

 

 

Date of purchase:

22 August 2024

Aggregate number of ordinary shares of £0.0001 each purchased:

275,000

Lowest price paid per share (GBp):

222.0

Highest price paid per share (GBp):

222.0

Volume weighted average price paid per share (GBp):

222.0

 

The Group will cancel the repurchased shares. Following the purchase of these shares, the remaining number of ordinary shares in issue will be 841,518,898 and the Group holds no ordinary shares in treasury. Therefore, the total voting rights in GlobalData will be 841,518,898. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Panmure Liberum Limited as part of the Share Buyback Programme.

 

Aggregate Information:

 

Venue

Volume-weighted average price (pence per share)

Aggregated volume

XLON

222.0

275,000

 

Individual transactions:

 

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Venue

275,000

222.0

10:46:16

AIMX

 

 

ENQUIRIES

 

GlobalData Plc

Mike Danson, Chief Executive Officer

0207 936 6400

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Liberum (Joint Broker)

0207 886 2500

Rupert Dearden

Dougie McLeod

Investec Bank plc (Joint Broker)

Henry Reast

Virginia Bull 

0207 597 5970

 

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

globaldata@fticonsulting.com

Dwight Burden

Emma Hall

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAKPAASFLEFA
Date   Source Headline
1st Aug 20247:00 amRNSPosting of Circular
1st Aug 20247:00 amRNSTransaction in Own Shares
31st Jul 20247:03 amRNSLaunch of Share Buyback Programme
31st Jul 20247:00 amRNSHalf Year Results
5th Jun 20247:00 amRNSUpdate re. Inflexion minority stake investment
2nd May 202410:16 amRNSDirector/PDMR Shareholding
2nd May 20247:00 amRNSAppointment of Joint Broker
23rd Apr 20242:44 pmRNSResults of Annual General Meeting
27th Mar 20247:00 amRNSAnnual Report for year ended 31 December 2023
12th Mar 20241:35 pmRNSDirector/PDMR Shareholding
12th Mar 20241:30 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSFull Year Results
1st Feb 20243:49 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSInvestor and Analyst Seminar
11th Jan 20247:00 amRNSTrading Update & Announcement of Investor Seminar
29th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSInvestment in Healthcare Division by Inflexion
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Sep 202310:48 amRNSDirector/PDMR Shareholding
13th Sep 202310:41 amRNSDirector/PDMR Shareholding
8th Aug 20235:41 pmRNSDirector/PDMR Shareholding
8th Aug 20235:35 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSHalf Year Results
25th Jul 20232:58 pmRNSResults of General Meeting
7th Jul 20237:00 amRNSNotice of General Meeting
30th Jun 202310:00 amRNSDirector/PDMR Shareholding
25th Apr 20233:34 pmRNSResult of AGM
25th Apr 20237:00 amRNSAGM Trading Update and Notice of AI Seminar
29th Mar 20237:00 amRNSNotice of Annual General Meeting 2023
17th Mar 20236:02 pmRNSAnnual Report for year ended 31 December 2022
27th Feb 20237:00 amRNSFull Year Results
27th Jan 20234:31 pmRNSDirector/PDMR Shareholding
27th Jan 20234:26 pmRNSHolding(s) in Company
27th Jan 20239:28 amRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSCapital Markets Day
18th Jan 202311:47 amRNSPDMR Dealing
10th Jan 20237:00 amRNSFull year trading update
10th Nov 20224:41 pmRNSSecond Price Monitoring Extn
10th Nov 20224:36 pmRNSPrice Monitoring Extension
17th Oct 20229:44 amRNSHoling(s) in Company
17th Oct 20228:44 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Sep 202210:59 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompletion of TS Lombard Acquisition
15th Aug 20227:00 amRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS£82m Share Scheme Vests for 146 Employees
10th Aug 20227:00 amRNS£410million Debt Financing Facility
1st Aug 20227:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.